October 2, 2025
Raamdeo_Agrawal
Shilpa Medicare’s spectacular jump of 17% today is not an isolated instance. Most of the stocks hand-picked by Raamdeo Agrawal as potential multi-baggers are sparkling
Shilpa Medicare’s spectacular jump of 17% today is not an isolated instance. Most of the stocks hand-picked by Raamdeo Agrawal as potential multi-baggers are sparkling




It is a matter of common sense that when accomplished investors of the caliber of Raamdeo Agrawal take time out to write a Wealth Creation Study and identify a handful of stocks as potential 100-baggers, we ought to take advantage of it.

Raamdeo Agrawal’s Wealth Creation Studies have proven credentials. We have earlier seen how well the five stocks chosen by him in the 2014 study have fared. One of the stocks is a 3+ bagger while the average return is 110% in one year.

The latest 19th Wealth Creation Study is packed with seven winner stocks. On an earlier occasion, I had evaluated the 3-month performance of these stocks. Five stocks had given absolute returns ranging from 21% to 62% while two were flat.

The strong performance continues unabated as is reflected in Shilpa Medicare’s stellar jump of 17% today. The same five stocks have given absolute returns ranging from 17% to 103%. Two are flat.

Here is the updated performance chart of the said seven stocks:

Stock Price on 10.11.2014 Price on 10.03.2015 Return (%)
Shilpa Medicare 559 925 65
Aarti Drugs 783 1339 71
Atul Auto 383 571 49
Tata Elxsi 629 1281 103
DCB Bank 93 109 17
Suven Lifescience 232 246 6
Granules India 761 821 7

We must bear in mind that these are small and mid-cap stocks and can be very volatile. Also, they are exposed to several risk factors which can derail the projections made by Raamdeo Agrawal. So, a SIP may be the best way to tuck into these stocks, if one is otherwise convinced about their fundamentals and is prepared to bear the volatility and risk factors.

4 thoughts on “Are You Still Taking Raamdeo Agrawal’s 100-Bagger Stocks For Granted?

  1. True we can’t take it for granted.
    Excellent article Arjun thanks for sharing this masterpiece.

    Regards
    bhs

    1. I do not see great fundamentals in any of these except DCB Bank, Tata Elxsi for its promoter pedigree…I can point to several other low fundamental stocks which have done equally well ….I wonder how these companies start performing in this bull market…this stock mentioned here is now more expensive than Lupin, Dr Reddy’s ….whats so special about it ? I am skeptical but I do go by the facts

  2. Stand corrected on Granules India….looks promising …but cannot say whether it will out perform the other pharma stocks

Leave a Reply to Bhs Cancel reply

Your email address will not be published. Required fields are marked *